ClinicalTrials.Veeva

Menu

FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Glioblastoma

Treatments

Diagnostic Test: Blood sample

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this interventional study is to investigate the correlation between Magnetic Resonance Phenotype and levels of FKBP51s protein pre and post surgery in adult patients affected by Glioblastoma

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >= 18 years
  • Diagnosis of Glioblastoma with surgery criteria
  • Brain MRI with contrast both pre and post surgery

Exclusion criteria

  • No availability of radiological documentation
  • Glioblastoma diagnosis not confirmed by Histological examination
  • Withdrawal of ICF

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

70 participants in 1 patient group

Single arm
Other group
Treatment:
Diagnostic Test: Blood sample

Trial contacts and locations

1

Loading...

Central trial contact

Simona Gaudino, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems